paper-with-me

홈 › Papers

Mass Flow Analysis of SARS-CoV-2 for quantified COVID-19 Risk Analysis

2020-10-29

How may exposure risks to SARS-CoV-2 be assessed quantitatively? The material metabolism approach of Industrial Ecology can be applied to the mass flows of these virions by their numbers, as a key step in the analysis of the current pandemic. Several transmission routes of SARS-2 from emission by a person to exposure of another person have been modelled and quantified. Start is a COVID-19 illness progression model specifying rising emissions by an infected person: the human virion factory. The first route covers closed spaces, with an emission, concentration, and decay model quantifying exposure. A next set of routes covers person-to-person contacts mostly in open spaces, modelling the spatial distribution of exhales towards inhalation. These models also cover incidental exposures, like coughs and sneezes, and exposure through objects. Routes through animal contacts, excrements, and food, have not been quantified. Potential exposures differ by six orders of magnitude. Closed rooms, even with reasonably (VR 2) to good (VR 5) ventilation, constitute the major exposure risks. Close person-to-person contacts of longer duration create two orders of magnitude lower exposure risks. Open spaces may create risks an order of magnitude lower again. Burst of larger droplets may cause a common cold but not viral pneumonia as the virions in such droplets cannot reach the alveoli. Fomites have not shown viable viruses in hospitals, let alone infections. Infection by animals might be possible, as by cats and ferrets kept as pets. These results indicate priority domains for individual and collective measures. The wide divergence in outcomes indicates robustness to most modelling and data improvements, hardly leading to major changes in relative exposure potentials. However, models and data can substantially be improved.

📄 PDF Abstract BibTeX arXiv:2010.07826

Code (0)

등록된 구현이 없습니다.

Similar Papers 제목 키워드 기반

DCcov: Repositioning of Drugs and Drug Combinations for SARS-CoV-2 Infected Lung through Constraint-Based Modelling

2021-03-25 · Ali Kishk, Maria Pires Pacheco, Thomas Sauter

The 2019 coronavirus disease (COVID-19) became a worldwide pandemic with currently no effective antiviral drug except treatments for symptomatic therapy. Flux balance analysis is an efficient method to analyze metabolic …

Massive viral replication and cytopathic effects in early COVID-19 pneumonia

2020-04-30 · L. Schifanella, J. L. Anderson, M. Galli, M. Corbellino 외

SARS-CoV-2 is the cause of COVID-19 acute respiratory illness that like its predecessors, MERS and SARS, can be severe and fatal 1-4. By April of 2020, COVID-19 infections had become a worldwide pandemic with nearly 3 mi…

COVID-19: The unreasonable effectiveness of simple models

2020-05-22

When the novel coronavirus disease SARS-CoV2 (COVID-19) was officially declared a pandemic by the WHO in March 2020, the scientific community had already braced up in the effort of making sense of the fast-growing wealth…

Breath analysis by ultra-sensitive broadband laser spectroscopy detects SARS-CoV-2 infection

2022-02-04 · Qizhong Liang, Ya-Chu Chan, Jutta Toscano, Kristen K. Bjorkman 외

Rapid testing is essential to fighting pandemics such as COVID-19, the disease caused by the SARS-CoV-2 virus. Exhaled human breath contains multiple volatile molecules providing powerful potential for non-invasive diagn…

BIG-bench Machine Learning

EDGE COVID-19: A Web Platform to generate submission-ready genomes for SARS-CoV-2 sequencing efforts

2020-06-15 · Chien-Chi Lo, Migun Shakya, Karen Davenport, Mark Flynn 외

Genomics has become an essential technology for surveilling emerging infectious disease outbreaks. A wide range of technologies and strategies for pathogen genome enrichment and sequencing are being used by laboratories …

Decision Making